Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
YiChang HEC ChangJiang Pharmaceutical Co. Ltd. Class H ( (HK:1558) ) has provided an update.
The recent joint announcement details the progress of the proposed pre-conditional privatization of YiChang HEC ChangJiang Pharmaceutical Co., Ltd. by Sunshine Lake Pharma Co., Ltd. through a merger by absorption. While one of the pre-conditions has been fulfilled, with filings made to the relevant authorities, the merger remains conditional on further approvals and filings, including those from the Stock Exchange and the China Securities Regulatory Commission. Stakeholders are advised that the merger agreement’s effectiveness is still uncertain, pending the fulfillment of these conditions.
More about YiChang HEC ChangJiang Pharmaceutical Co. Ltd. Class H
YiChang HEC ChangJiang Pharmaceutical Co., Ltd. is a company incorporated in the People’s Republic of China and operates within the pharmaceutical industry. It is involved in the development and production of pharmaceuticals, focusing on serving the healthcare market.
YTD Price Performance: -2.09%
Average Trading Volume: 2,970,794
Technical Sentiment Consensus Rating: Hold
Current Market Cap: HK$8.24B
See more data about 1558 stock on TipRanks’ Stock Analysis page.
